The role of L-arginine following trauma and blood loss

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 10, Issue 1, 2007, Pages 80-87

  Loehe, Florian ^a   Bruns, Christiane Josephine ^a   Nitsch, Stefan Martin ^b   Angele, Martin Kurt ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b University of Schleswig Holstein   (Germany)

Author keywords

Hemorrhage; Immune dysfunction; Immunonutrition; L arginine; Surgery

Indexed keywords

ARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASOPRESSIN;

BLEEDING; CARDIOVASCULAR FUNCTION; CELLULAR IMMUNITY; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; ENDOTHELIAL DYSFUNCTION; HUMAN; INFLAMMATION; INJURY; LIVER INJURY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; ORGAN BLOOD FLOW; REVIEW; SHOCK; SMOOTH MUSCLE TONE; TISSUE INJURY; VASCULAR ENDOTHELIUM; WOUND HEALING;

ANIMALS; ARGININE; CRITICAL ILLNESS; HUMANS; IMMUNITY, CELLULAR; NITRIC OXIDE; NITRIC OXIDE DONORS; REGIONAL BLOOD FLOW; SHOCK, HEMORRHAGIC; WOUND HEALING; WOUNDS AND INJURIES;

ANIMALIA;

EID: 33845403249     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328011bb1b     Document Type: Review

References (78)

1. Moncada S, Higgs EA. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329:2002-2012.
2. Furchgott RF. Role of endothelium in response of vascular smooth muscle. Circ Res 1980; 53:557-573.
3. Weyrich AS, Ma X, Lefer AM. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 1992; 86:279-288.
4. Ignarro LJ. Biological actions and properties of endothelium derived nitric oxide formed and released from artery and vein. Circ Res 1989; 65:1-21.
5. McCall TB, Broughton-Smith NK, Palmer RM, et al. Synthesis of nitric oxide from L-arginine by neutrophils: release and interaction with superoxide anion. Biochem J 1989; 261:293-296.
6. Wang P, Ba ZF, Chaudry IH. Endothelial cell dysfunction occurs very early following trauma-hemorrhage and persists despite fluid resuscitation. Am J Physiol 1993; 265:H973-H979.
7. Szabo C, Thiemermann C. Invited opinion: role of nitric oxide in hemorrhagic, traumatic, and anaphylactic shock and thermal injury. Shock 1994; 2:145-155.
8. Lefer AM. Endotoxin, cytokines, and nitric oxide in shock: an editorial comment. Shock 1994; 1:79-80.
9. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB 1992; 6:3051-3064.
10. Angele MK, Fitzal F, Smail N, et al. L-Arginine attenuates trauma-hemorrhage induced liver injury. Crit Care Med 2000; 28:3242-3248.
11. Bansal V, Ochoa JB. Arginine availability, arginase, and the immune response. Curr Opin Clin Nutr Metab Care 2003; 6:223-228.
12. Cendan JC, Souba WW, Copeland EM III, Lind DS. Cytokine regulate endotoxin stimulation of endothelial cell arginine transport. Surgery 1995; 117:213-219.
13. Bernard AC, Mistry SK, Morris SM Jr, et al. Alterations in arginine metabolic enzymes in trauma. Shock 2001; 15:215-219.
14. Wang P, Hauptman JG, Chaudry IH. Hemorrhage produces depression in microvascular blood flow which persists despite fluid resuscitation. Circ Shock 1990; 32:307-318.
15. Angele MK, Smail N, Wang P, et al. L-Arginine restores the depressed cardiac output and regional perfusion following trauma-hemorrhage. Surgery 1998; 124:394-401.
16. Angele MK, Smail N, Knoferl MW, et al. L-Arginine restores splenocyte functions after trauma-hemorrhage potentially by improving splenic blood flow. Am J Physiol 1999; 276:C145-C151.
17. Sun BL, Zhang SM, Xia ZL, et al. L-Arginine improves cerebral blood perfusion and vasomotion of microvessels following subarachnoid hemorrhage in rats. Clin Hemorheol Microcirc 2003; 29 (3-4):391-400.
18. Nakanishi K, Vinten-Johansen J, Lefer DJ, et al. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. Am J Physiol 1992; 263:H1650-H1658.
19. Spain DA, Wilson MA, Bar-Natan MF, Garrison RN. Role of nitric oxide in the small intestinal microcirculation during bacteremia. Shock 1994; 2:41-46.
20. +-ATPase and nitric oxide synthase activity in segmental small-bowel autotransplantation model. World J Gastroenterol 2005; 11:3605-3609.
21. Ertel W, Morrison MH, Ayala A, Chaudry IH. Hypoxemia in the absence of blood loss or significant hypotension causes inflammatory cytokine release. Am J Physiol 1995; 269:R160-R166.
22. Chaudry IH, Ayala A. Immunological aspects of hemorrhage. Austin, TX: Medical Intelligence Unit, R.G. Landes Company; 1992.
23. 2 on portal and hepatic blood flow following hemorrhage and resuscitation. Am J Physiol 1992; 263:G895-G900.
24. Chaudry IH, Ayala A. Immune consequences of hypovolemic shock and resuscitation. Curr Opin Anaesthesiology 1993; 6:385-392.
25. Lhuillier F, Robert MO, Crova P, et al. Nitric oxide and liver microcirculation during autoregulation and haemorrhagic shock in rabbit model. Br J Anaesth 2006; 97:137-146. Enzyme-dependent nitric oxide release controls liver microcirculation following hemorrhage.
26. Harbrecht BG, Wu B, Watkins SC, et al. Inhibition of nitric oxide synthesis during severe shock but not after resuscitation increases hepatic injury and neutrophil accumulation in hemorrhaged rats. Shock 1997; 8:415-421.
27. Schneider R, Raff U, Vornberger N, et al. L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats. Kidney Int 2003; 64:216-225.
28. Benyo Z, Szabo C, Csaki C, et al. Effect of L-arginine on adrenal and renal blood flows during hemorrhage in cats. Kidney Int Suppl 1998; 67:221-223.
29. Anaya-Prado R, Toledo-Pereyra LH, Walsh J, et al. Exogenous nitric oxide donor and related compounds protect against lung inflammatory response after hemorrhagic shock and resuscitation. J Trauma 2004; 57:980-988.
30. Loehe F, Preissler G, Annecke T, et al. Continuous infusion of nitroglycerin improves pulmonary graft function of nonheart-beating donor lungs. Transplantation 2004; 77:1803-1808.
31. Daughters K, Waxman K, Nguyen H. Increasing nitric oxide production improves survival in experimental hemorrhagic shock. Resuscitation 1996; 31:141-144.
32. Angele MK, Chaudry IH. Surgical trauma and immunosuppression: pathophysiology and potential immunomodulatory approaches. Langenbecks Arch Surg 2005; 390:333-341.
33. Angele MK, Smail N, Ayala A, et al. L-Arginine: a unique amino acid for restoring the depressed immune functions after trauma-hemorrhage. J Trauma 1998; 46:34-41.
34. Meldrum DR, McIntyre RC Jr, Sheridan BC, et al. L-Arginine decreases alveolar macrophage proinflammatory monokine production during acute lung injury by a nitric oxide synthase-dependent mechanism. J Trauma 1997; 43:888-893.
35. Cui XL, Iwasa M, Iwasa Y, Ogoshi S. Arginine-supplemented diet decreases expression of inflammatory cytokines and improves survival in burned rats. JPEN J Parenter Enteral Nutr 2000; 24:89-96.
36. Braga M, Gianotti L, Vignali A, Carlo VD. Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery 2002; 132:805-814.
37. Matsuda A, Furukawa K, Takasaki H, et al. Preoperative oral immune-enhancing nutritional supplementation corrects TH1/TH2 imbalance in patients undergoing elective surgery for colorectal cancer. Dis Colon Rectum 2006; 49:507-516. This clinical study on 36 patients with colorectal resections nicely elucidates the potential of L-arginine treatment to prevent the loss of Th1 responses. Maintained Th1 responses, however, are important for the control of infectious complications. Thus, in a homogenous patient, collective L-arginine might be beneficial.
38. Marin VB, Rodriguez-Osiac L, Schlessinger L, et al. Controlled study of enteral arginine supplementation in burned children: impact on immunologic and metabolic status. Nutrition 2006; 22:705-712.
39. Moriguti JC, Ferriolli E, Donadi EA, Marchini JS. Effects of arginine supplementation on the humoral and innate immune response of older people. Eur J Clin Nutr 2005; 59:1362-1366.
40. Diegelman RF, Lindblad WJ, Cohen IK. A subcutaneous implant for wound healing studies in humans. J Surg Res 1986; 40:229-237.
41. Guiney DJ, Morris PJ, Donaldson GA. Wound dehiscence: a continuing problem in abdominal surgery. Arch Surg 1966; 92:47-51.
42. McGinn FP. Effects of hemorrhage upon surgical operations. Br J Surg 1976; 63:742-746.
43. Crowley LV, Seifter E, Kriss P, et al. Effects of environmental temperature and femoral fracture on wound healing in rats. J Trauma 1977; 17:436-445.
44. Goris R, Te Boekhorst T, Nuytinck J. Multiple-organ failure: generalized autodestructive inflammation. Arch Surg 1985; 120:1109.
45. Hunt TK, Knighton D, Goodson W. Wound healing in current surgical diagnosis and treatment. Crit Care Med 1988; 16:86-98.
46. Martin P. Wound healing: aiming for perfect skin regeneration. Science 1997; 276:75-81.
47. Hunt TK, Hussian Z. Wound environment. In: Cohen K, Diegelmann RF, Lindblad WJ, editors. Wound healing biochemical and clinical aspects. Philadelphia: Saunders; 1992. pp. 274-281.
48. Angele MK, Knoferl MW, Schwacha MG, et al. Hemorrhage decreases macrophage inflammatory protein-2 (MIP-2) and IL-6 release: a possible mechanism for increased wound infection. Ann Surg 1999; 229:651-661.
49. Angele MK, Knoferl MW, Ayala A, et al. Trauma-hemorrhage delays wound healing potentially by increasing proinflammatory cytokines at the wound site. Surgery 1999; 126:279-285.
50. Livingston DH, Malangoni MA. Prolonged susceptibility to infection exists after hemorrhagic shock despite resuscitation and antibiotics. Surg Forum 1987; 38:64-67.
51. Angele MK, Knoferl MW, Schwacha MG, et al. Decreased collagen deposition at the wound site following hemorrhage: a potential mechanism for impaired wound healing. Crit Care Shock 2000; 3:49-56.
52. Angele MK, Nitsch SM, Hernandez-Richter T, et al. L-Arginine: a unique amino acid for improving depressed wound immune function following hemorrhage. Eur Surg Research 2002; 34:53-60.
53. Wittmann F, Prix N, Mayr S, et al. L-Arginine improves wound healing after trauma-hemorrhage by increasing collagen synthesis. J Trauma 2005; 59:162-168. In addition to wound immune cell function, L-Arginine improves the wound-healing process and increases the maximal wound breaking strength following hemorrhage. This healing advantage in L-arginine-treated animals might contribute to reduce the rate of postoperative morbidity.
54. Kirk SJ, Hurson M, Regan MC, et al. Arginine stimulates wound healing and immune function in elderly human beings. Surgery 1993; 114:155-159.
55. Williams JZ, Abumrad N, Barbul A. Effect of a specialized amino acid mixture on human collagen deposition. Ann Surg 2002; 236:369-374.
56. Seifter E, Rettura G, Barbul A, Levenson SM. Arginine: an essential amino acid for injured rats. Surgery 1978; 84:224-230.
57. Furchgott RF. Studies on endothelium-dependent vasodilation and the endothelium-derived relaxing factor. Acta Physiol Scand 1990; 139:257-270.
58. Shenkar R, Cohen AJ, Vestweber D, et al. Hemorrhage and resuscitation alter the expression of ICAM-1 and P-selectin in mice. J Inflamm 1995; 45:248-259.
59. Albina JE, Reichner JS. Nitric oxide in inflammation and immunity. New Horizons 1995; 3:46-64.
60. Angele MK, Schwacha MG, Smail N, et al. Hypoxemia in the absence of blood loss upregulates iNOS expression and activity in macrophages. Am J Physiol 1999; 276:C285-C290.
61. Liu LM, Dubick MA. Hemorrhagic shock-induced vascular hyporeactivity in the rat: relationship to gene expression of nitric oxide synthase, endothelin-1, and select cytokines in corresponding organs. J Surg Res 2005; 125:128-136. This study investigates the expression of iNOS in different compartments, thereby better defining the pathophysiological mechanisms following hemorrhage.
62. Collins JL, Vodovotz Y, Hierholzer C, et al. Characterization of the expression of inducible nitric oxide synthase in rat and human liver during hemorrhagic shock. Shock 2003; 19:117-122.
63. Smail N, Catania RA, Wang P, et al. Gut and liver: The organs responsible for increased nitric oxide production after trauma-hemorrhage and resuscitation. Arch Surg 1998; 133:399-405.
64. Hallemeesch MM, Janssen BJ, de Jonge WJ, et al. NO production by cNOS and iNOS reflects blood pressure changes in LPS-challenged mice. Am J Physiol Endocrinol Metab 2003; 285:E871-E875.
65. Villalpando S, Gopal J, Balasubramanyam A, et al. In vivo arginine production and intravascular nitric oxide synthesis in hypotensive sepsis. Am J Clin Nutr 2006; 84:197-203.
66. Connelly L, Madhani M, Hobbs AJ. Resistance to endotoxic shock in endothelial nitric-oxide synthase (eNOS) knock-out mice: a pro-inflammatory role for eNOS-derived NO in vivo. J Biol Chem 2005; 280:10040-10046.
67. Kalil AC, Danner RL. L-Arginine supplementation in sepsis: beneficial or harmful? Curr Opin Crit Care 2006; 12:303-308. The authors critically review the current literature on L-arginine treatment in patients, pointing out the potential risk of a routine supra-physiological L-arginine supplementation.
68. Moore FA, Moore EE, Kudsk KA, et al. Clinical benefits of immune-enhancing diet for early postinjury enteral feeding. J Trauma 1994; 37:607-613.
69. Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 1999; 27:2799-2805.
70. Heys SD, Walker LG, Smith I, Eremin O. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg 1999; 229:467-477.
71. Heyland DK, Novak F, Drover JW, et al. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001; 286:944-953.
72. Montejo JC, Zarazaga A, Lopez-Martinez J, et al. Immunonutrition in the intensive care unit: a systematic review and consensus statement. Clin Nutr 2003; 22:221-233.
73. Luckner G, Dunser MW, Jochberger S, et al. Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med 2005; 33:2659-2666.
74. Lind DS. Arginine and cancer. J Nutr 2004; 134(10 Suppl):2837S-2841S.
75. Heyland DK, Novak F. Immunonutrition in the critically ill patient: more harm than good? JPEN J Parenter Enteral Nutr 2001; 25(2 Suppl):S51-S55.
76. Kalil AC, Sevransky JE, Myers DE, et al. Preclinical trial of L-arginine monotherapy alone or with N-acetylcysteine in septic shock. Crit Care Med 2006; 34:2719-2728.
77. Van Buren CT. Arginine immunonutrition in critically ill patients. Am J Crit Care 2004; 13:290.
78. Cynober L. Immune-enhancing diets for stressed patients with a special emphasis on arginine content: analysis of the analysis. Curr Opin Clin Nutr Metab Care 2003; 6:189-193.